PlainPharmaWatch

CMS Open Payments · Program Year 2024

New Hampshire

New Hampshire received $9,359,725.20 in pharmaceutical-industry payments to 2,511 physicians and 4 teaching hospitals across 34,902 transactions.

$9.4M
Total payments
$7.0M
To physicians
$1.5M
To teaching hospitals
#39
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $9.4M in payments to 2,511 physicians and 4 teaching hospitals in New Hampshire. That ranks New Hampshire #39 of 59 states and territories (0.1% of the US total), averaging $2.8K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

New Hampshire pairs below-median payment volume with a physician-heavy payment mix.

#39
of 59 states
0.1%
of the national total
75.1%
to physicians vs. hospitals
2,511
physicians paid

What the Data Shows for New Hampshire

New Hampshire's Open Payments file is hospital-weighted: 16.0% of $9.4M went to 4 teaching hospitals ($374.0K each), with 75.1% on 2,511 physicians.

Volume rank is #39 of 59: mid-pack dollars with the mix as the distinctive cut. Average transaction $268.17. Leading nature of payment: "Compensation for Services Other Than Consulting" at $4.2M (44.8% of the state file; top-three natures 75.2%).

New Hampshire sits in the 36th percentile (lower-volume tier). Just above: Idaho ($12.2M). Just below: Nebraska ($9.3M). For context: top-ranked California ($342.4M) is 36.6× larger than New Hampshire. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in New Hampshire are distributed between physicians and teaching hospitals.

Physician Payments

$7.0M

75.1% of total · 2,511 recipients · $2.8K avg

Teaching Hospital Payments

$1.5M

16.0% of total · 4 hospitals · $374.0K avg

Payment Breakdown by Type

New Hampshire has 14 types of pharmaceutical payments. "Compensation for Services Other Than Consulting" accounts for 44.8%.

Nature concentration in New Hampshire

Top three Open Payments natures are 75.2% of state dollars; residual is every other reported nature

Compensation for Services Ot…$4.2MConsulting Fee$1.8MFood and Beverage$1.0MAll other natures (11)$2.3M

Payment categories in New Hampshire

Top categories by total reported dollar volume

1. Compensation for Services…$4.2M2. Consulting Fee$1.8M3. Food and Beverage$1.0M4. Royalty or License$1.0M5. Travel and Lodging$764.8K6. Education$243.1K7. Grant$72.8K8. Compensation for Faculty …$61.3K9. Space Rental or Facility …$55.9K10. Honoraria$36.9K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $4.2M 1,008
Consulting Fee $1.8M 610
Food and Beverage $1.0M 30,019
Royalty or License $1.0M 40
Travel and Lodging $764.8K 2,337
Education $243.1K 573
Grant $72.8K 23
Compensation for Faculty or Speaker (Medical Education) $61.3K 35
Space Rental or Facility Fees $55.9K 24
Honoraria $36.9K 35
Debt Forgiveness $33.8K 11
Gift $23.4K 134
Long-Term Medical Supply or Device Loan $21.8K 14
Entertainment $2.0K 39

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What New Hampshire totals can and cannot tell you

The aggregate payment figure for New Hampshire measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download New Hampshire's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.